Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02874898 · ClinicalTrials.gov registry record · NA
Short-Term Exposure for PTSD
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT02874898 is a NA study that has completed, run by University of Washington. The registered enrollment target is 46 participants.
The verdict
NCT02874898, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
This study examines how marijuana use affects processes related to recovery from chronic posttraumatic stress disorder (PTSD). Half the participants will be individuals with chronic PTSD and heavy marijuana use and half will be individuals with chronic PTSD and no marijuana use. This study will assess how individuals with PTSD with heavy or no marijuana use perform on a discriminative conditioning and extinction paradigm designed to measure fear extinction learning, and how they respond to a brief daily imaginal exposure treatment in regards to PTSD symptom reduction.
Interventions
- BEHAVIORAL Brief Imaginal Exposure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2016-06 |
| Est. Completion | 2022-08-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02874898
The ClinicalTrials.gov registry entry for NCT02874898 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Brief Imaginal Exposure is the first listed.
NCT02874898 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02874898 about?
NCT02874898 is a clinical study titled "Short-Term Exposure for PTSD". This study examines how marijuana use affects processes related to recovery from chronic posttraumatic stress disorder (PTSD). Half the participants will be individuals with chronic PTSD and heavy marijuana use and half will be individuals with chronic PTSD and no marijuana use. This study will asse...
What is the current status of trial NCT02874898?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2016-06. Estimated completion is 2022-08-15.
What interventions are being tested in trial NCT02874898?
The interventions under investigation include: Brief Imaginal Exposure (BEHAVIORAL).
Who is sponsoring clinical trial NCT02874898?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.